Product Images Fluticasone Propionate And Salmeterol Hfa
View Photos of Packaging, Labels & Appearance
Product Label Images
The following 19 images provide visual information about the product associated with Fluticasone Propionate And Salmeterol Hfa NDC 66993-087 by Prasco Laboratories, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
This appears to be a chart or table with medication dosages and a placebo. It includes information on the change in FEVy (likely a measure of lung function) over time for each treatment, as well as the number of participants in each group. Without more context, it is difficult to provide a more detailed description or interpretation of the data.*
This text describes a study involving the use of two inhalers containing Fluticasone propionate and salmeterol HFA, as well as placebos. The study involved a total of 85 participants in the first group, who used the Fluticasone propionate and salmeterol inhaler, 75 participants in the second group, who used only the Fluticasone propionate inhaler, 63 participants in the third group, who used only the Salmeterol inhaler, and 56 participants in the placebo group. The study evaluated the change in FEV relative to the baseline on day 1, over a period of 12 weeks. However, the values of FEV changes are not provided in the text.*
This is a metal canister with a purple plastic actuator and mouthpiece. It also has a counter light purple cap.*
This is likely a product label or instruction manual for a device with a purple mouthpiece and cap. The label mentions a "Mouthpiece-Down position," but further context or information about the device is not available.*
This is a description of a medication with the NDC number 66993-086-96, made by PRASCO. It is a Fluticasone Propionate and Salmeterol HFA Inhaler with Rerosol 45 mcg/21 meg. The medicine is for oral inhalation but only with Fluticasone Propionate and Salmeterol HFA actuator. The canister holds a microcrystalline suspension containing fluticasone propionate and salmeterol xinafoate in propellant HFA-134a. Each spray contains 45 mcg of fluticasone propionate and 30.45 mcg of salmeterol xinafoate equivalent et 1021 meg of salmeterol base gz from the mouthpiece. It has 120 metered actuations and a net weight of 12g. Dosage information can be found in the prescribing information. It is a prescription drug.*
This text is a description of a medication named Fluticasone Propionate and Salmeterol HFA Inhalation. It contains the drug's name, the manufacturer's name (PRASCO), and the product's NDC code (66993-087-96). It specifies that the medication is for oral inhalation and comes in a canister that contains a microcrystalline suspension of Fluticasone Propionate and Salmeterol Xinafoate in propellant HFA-134a. The medication's dosage information can be found in the prescribing information. The medication is only available with a prescription. The product contains 120 metered actuations and weighs 12g.*
This is the description for NDC 66993-088-96, a Fluticasone Propionate and Salmeterol HFA Inhalation aerosol for oral inhalation. It has 230 mcg of Fluticasone Propionate and 30.45 mcg of Salmeterol Xinafoate equivalent to 21 mcg of salmeterol base for each actuation. It comes in a canister with 120 metered actuations and is only for use with Fluticasone Propionate and Salmeterol HFA actuator. Prescription is required and dosage information is provided in the prescribing information.*
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.